NYSE:BMY Bristol-Myers Squibb - BMY Earnings Date, Estimates & Call Transcripts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. $67.51 +0.27 (+0.40%) (As of 03/21/2023 04:00 PM ET) Add Compare Share Share Today's Range$66.87▼$67.8150-Day Range$65.71▼$74.5352-Week Range$65.28▼$81.43Volume8.04 million shsAverage Volume8.47 million shsMarket Capitalization$141.69 billionP/E Ratio22.88Dividend Yield3.38%Price Target$79.69 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Earnings Summary Upcoming Earnings DateApr. 27ConfirmedActual EPS (Feb. 2) $1.82 Beat By $0.11 Consensus EPS (Feb. 2) $1.71 Last Year's Q1 EPS (2/4/2022) $1.83Read Call TranscriptListen to CallSkip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBMY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BMY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.Bristol-Myers Squibb Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20233$1.92$2.02$1.98 Q2 20233$1.94$2.06$2.00 Q3 20232$1.90$1.99$1.95 Q4 20233$1.79$2.02$1.88 FY 202311$7.55$8.09$7.81 Q1 20242$2.03$2.03$2.03 Q2 20242$1.98$2.12$2.05 Q3 20241$2.03$2.03$2.03 Q4 20241$1.69$1.69$1.69 FY 20246$7.73$7.87 $7.80 Get Bristol-Myers Squibb Earnings AlertsEnter your email address below to receive the latest news and earnings results for BMY and its competitors with MarketBeat's FREE daily newsletter. BMY Earnings Date and InformationBristol-Myers Squibb last posted its earnings results on February 2nd, 2023. The biopharmaceutical company reported $1.82 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.11. The firm had revenue of $11.41 billion for the quarter, compared to analysts' expectations of $11.20 billion. Its quarterly revenue was down 4.8% compared to the same quarter last year. Bristol-Myers Squibb has generated $2.95 earnings per share over the last year ($2.95 diluted earnings per share) and currently has a price-to-earnings ratio of 22.9. Earnings for Bristol-Myers Squibb are expected to decrease by -1.12% in the coming year, from $8.06 to $7.97 per share. Bristol-Myers Squibb has confirmed that its next quarterly earnings report will be published on Thursday, April 27th, 2023. Bristol-Myers Squibb will be holding an earnings conference call on Thursday, April 27th at 8:00 AM Eastern. Interested parties can register for or listen to the call. or dial in at 647-362-9199 with passcode "3734085". Read More Bristol-Myers Squibb Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/27/2023(Confirmed) $1.99 2/2/2023Q4 2022$1.71$1.82+$0.11$2.69$11.20 billion$11.41 billion 10/25/2022Q3 2022$1.83$1.99+$0.16$3.23$11.18 billion$11.22 billion 7/27/2022Q2 2022$1.79$1.93+$0.14$3.20$11.50 billion$11.89 billion 4/29/2022Q1 2022$1.92$1.96+$0.04$3.33$11.34 billion$11.65 billion 2/4/2022Q4 2021$1.83$1.83$2.59$12.00 billion$11.96 billion 10/26/20219/30/2021$1.92$2.00+$0.08$3.31$11.52 billion$11.62 billion 7/27/20216/30/2021$1.89$1.93+$0.04$3.39$11.24 billion$11.70 billion 4/28/20213/31/2021$1.82$1.74($0.08)$2.59$11.19 billion$11.07 billion 2/3/202112/31/2020$1.42$1.46+$0.04$7.37$10.74 billion$11.07 billion 11/10/20209/30/2020$1.49$1.63+$0.14$2.44$10.33 billion$10.54 billion 8/6/20206/30/2020$1.48$1.63+$0.15$3.30$10.04 billion$10.13 billion 5/7/20203/31/2020$1.49$1.72+$0.23$3.78$10.04 billion$10.78 billion 2/6/202012/31/2019$0.88$1.22+$0.34$2.99$6.20 billion$7.95 billion 10/31/2019Q3 2019$2.70$2.99+$0.29$3.18$4.39 billion$4.52 billion 10/31/2019Q3 2019$1.06$1.17+$0.11$1.51$5.89 billion$6.01 billion 7/30/2019Q2$2.44$2.61+$0.17$3.06$4.22 billion$4.40 billion 7/25/20196/30/2019$1.06$1.18+$0.12$1.49$6.10 billion$6.27 billion 4/25/2019Q1 2019$2.45$2.55+$0.10$2.42$4.01 billion$4.03 billion 4/25/20193/31/2019$1.09$1.10+$0.01$1.16$5.72 billion$5.92 billion 1/31/2019Q4$2.32$2.39+$0.07$2.90$3.98 billion$4.04 billion1/24/2019Q4 2018$0.85$0.94+$0.09$1.15$5.95 billion$5.97 billion10/25/20189/30/2018$2.02$2.29+$0.27$2.56$3.83 billion$3.89 billion 10/25/20189/30/2018$0.91$1.09+$0.18$1.02$5.72 billion$5.69 billion 7/26/2018Q2 2018$2.11$2.16+$0.05$2.29$3.70 billion$3.81 billion 7/26/2018Q2 2018$0.87$1.01+$0.14$1.79$5.48 billion$5.70 billion 5/4/2018Q1 2018$1.96$2.05+$0.09$2.12$3.47 billion$3.54 billion4/26/2018Q1 2018$0.85$0.94+$0.09$0.97$5.25 billion$5.19 billion 2/5/2018Q4 2017$0.67$0.68+$0.01$2.78$5.35 billion$5.45 billion 1/25/2018Q4 2017$1.78$1.87+$0.09$3.84$3.46 billion$3.48 billion 10/26/2017Q3 2017$1.87$1.91+$0.04$2.35$3.42 billion$3.29 billion10/26/2017Q3 2017$0.77$0.75($0.02)$0.99$5.20 billion$5.25 billion7/27/20176/30/2017$1.61$1.82+$0.21$2.05$3.23 billion$3.27 billion7/27/2017Q2 2017$0.73$0.74+$0.01$0.92$5.09 billion$5.14 billion4/27/2017Q1 2017$1.47$1.68+$0.21$1.90$3.04 billion$2.96 billion4/27/2017Q1 2017$0.72$0.84+$0.12$0.74$4.75 billion$4.93 billion1/26/2017Q416$1.59$1.61+$0.02$2.29$3.03 billion$2.98 billion1/26/2017Q416$0.67$0.63($0.04)$0.73$5.14 billion$5.24 billion10/27/2016Q316$1.31$1.58+$0.27$2.57$2.84 billion$2.98 billion 10/27/2016Q316$0.65$0.77+$0.12$0.82$4.76 billion$4.83 billion 7/28/2016Q216$1.39$1.44+$0.05$1.81$2.70 billion$2.74 billion 7/28/2016Q216$0.67$0.69+$0.02$0.69$4.60 billion$4.90 billion 4/28/2016Q116$1.29$1.32+$0.03$1.37$2.59 billion$2.51 billion 4/28/2016Q116$0.65$0.74+$0.09$0.77$4.19 billion$4.39 billion 1/28/2016Q415$1.22$1.18($0.04)$1.31$2.54 billion$2.54 billion 1/28/2016Q415$0.28$0.38+$0.10$0.84$4.07 billion$4.29 billion 11/5/2015Q315$1.09$1.23+$0.14$2.28$2.40 billion$2.33 billion10/27/2015Q315$0.35$0.39+$0.04$0.36$3.83 billion$4.07 billion 7/23/2015Q215$1.08$1.23+$0.15$1.73$2.24 billion$2.28 billion 7/23/2015Q215$0.36$0.53+$0.17$1.14$3.68 billion$4.16 billion 4/30/2015Q115$0.93$0.95+$0.02$1.04$2.11 billion$2.08 billion4/28/2015Q115$0.50$0.71+$0.21$0.71$3.80 billion$4.04 billion1/29/2015Q414$0.88$0.91+$0.03$1.08$2.08 billion$2.09 billion1/27/2015Q414$0.40$0.46+$0.06$0.91$4.02 billion$4.26 billion10/24/2014Q314$0.42$0.45+$0.03$0.47$3.80 billion$3.92 billion 10/23/2014Q314$0.82$0.97+$0.15$1.15$1.96 billion$1.96 billion 7/24/2014Q214$0.77$0.80+$0.03$0.88$1.85 billion$1.87 billion7/24/2014Q214$0.44$0.48+$0.04$0.76$3.85 billion$3.89 billion 4/29/2014Q114$0.43$0.46+$0.03$0.36$3.89 billion$3.81 billion 4/24/2014Q114$1.65$1.67+$0.02$1.13$1.77 billion$1.71 billion 1/30/2014Q4 2013$0.70$0.67($0.03)$1.09$1.72 billion$1.76 billion 1/24/2014Q4 2013$0.43$0.51+$0.08$0.58$4.30 billion$4.44 billion 10/24/2013Q3 2013$0.69$0.70+$0.01$0.96$1.64 billion$1.67 billion10/23/2013Q3 2013$0.44$0.46+$0.02$0.50$4.02 billion$4.07 billion 7/25/2013Q2 2013$0.65$0.70+$0.05$0.84$1.54 billion$1.56 billion 7/25/2013Q2 2013$0.44$0.44$0.56$4.07 billion$4.05 billion 4/25/2013Q1 2013$0.62$0.63+$0.01$0.81$1.47 billion$1.43 billion 4/25/2013Q1 2013$0.41$0.41$0.45$3.88 billion$3.83 billion 1/24/2013Q4 2012$1.31$1.32+$0.01$1.45 billion$1.42 billion 1/24/2013Q4 2012$0.42$0.47+$0.05$4.14 billion$4.19 billion 10/25/2012$1.26$1.29+$0.03 10/24/2012$0.42$0.41($0.01) 7/26/2012$1.19$1.22+$0.037/25/2012$0.48$0.484/26/2012$1.13$1.08($0.05)4/26/2012$0.64$0.641/26/2012$1.06$1.05($0.01)1/26/2012$0.55$0.53($0.02)10/27/2011$0.95$1.02+$0.0710/27/2011$0.58$0.61+$0.037/28/2011$0.85$0.89+$0.047/28/2011$0.55$0.56+$0.014/28/2011$0.80$0.83+$0.034/28/2011$0.53$0.58+$0.051/27/2011$0.73$0.731/27/2011$0.48$0.47($0.01) 10/28/2010Q3 2010$0.32$0.32$0.347/29/2010Q2 2010$0.30$0.30$0.434/29/2010Q1 2010$0.28$0.27($0.01)$0.291/28/2010Q4 2009$0.29$0.29$0.3110/22/2009Q3 2009$0.25$0.25$0.277/23/2009Q2 2009$0.21$0.20($0.01)$0.254/30/2009Q1 2009$0.20$0.16($0.04)$0.151/29/2009Q4 2008$0.19$0.19$0.5410/23/2008Q3 2008$0.18$0.17($0.01)$0.197/24/2008Q2 2008$0.16$0.15($0.01)$0.175/8/2008Q1 2008$0.16$0.17+$0.01$2.331/31/2008Q4 2007$0.15$0.15$0.21Bristol-Myers Squibb Earnings - Frequently Asked Questions When is Bristol-Myers Squibb's earnings date? Bristol-Myers Squibb has confirmed that its next quarterly earnings data will be published on Thursday, April 27th, 2023. Learn more on BMY's earnings history. Did Bristol-Myers Squibb beat their earnings estimates last quarter? In the previous quarter, Bristol-Myers Squibb (NYSE:BMY) reported $1.82 earnings per share (EPS) to beat the analysts' consensus estimate of $1.71 by $0.11. Learn more on analysts' earnings estimate vs. BMY's actual earnings. How can I listen to Bristol-Myers Squibb's earnings conference call? The conference call for Bristol-Myers Squibb's latest earnings report can be listened to online. Listen to Conference Call How can I read Bristol-Myers Squibb's conference call transcript? The conference call transcript for Bristol-Myers Squibb's latest earnings report can be read online. Read Transcript How much revenue does Bristol-Myers Squibb generate each year? Bristol-Myers Squibb (NYSE:BMY) has a recorded annual revenue of $46.16 billion. How much profit does Bristol-Myers Squibb generate each year? Bristol-Myers Squibb (NYSE:BMY) has a recorded net income of $6.33 billion. BMY has generated $2.95 earnings per share over the last four quarters. What is Bristol-Myers Squibb's price-to-earnings ratio? Bristol-Myers Squibb (NYSE:BMY) has a trailing price-to-earnings ratio of 22.88 and a forward price-to-earnings ratio of 8.38. The price/earnings-to-growth ratio is 1.45. What is Bristol-Myers Squibb's EPS forecast for next year? Bristol-Myers Squibb's earnings are expected to decrease from $8.06 per share to $7.97 per share in the next year, which is a -1.12% change. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: General Mills Retreats To Buy Zone Ahead Of Earnings FedEx Is A Buy Going Into Earnings Potential Earnings Have Rated Ambrx Biopharma a Moderate BuyLemonade Earnings Gap and Crap. Here’s Why.Is Unity Software Earnings Fallout a Buying Opportunity?Kohl's Earnings Were So Bad. They're Actually Good West Fraser's Earnings Scream Timber, Outlook Says Buy Upcoming Earnings: Accenture (3/23/2023)Micron Technology (3/28/2023)BlackRock (4/12/2023)Infosys (4/12/2023)Progressive (4/13/2023)Taiwan Semiconductor Manufacturing (4/13/2023)UnitedHealth Group (4/13/2023)U.S. Bancorp (4/13/2023)Wells Fargo & Company (4/13/2023)Citigroup (4/14/2023) This page (NYSE:BMY) was last updated on 3/21/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.